Rockeby biomed will continue to develop the commercialisation of its key products whilst ensuring it maintains a broad portfolio of research and development activity.
 |
 |
 |
- Shareholder Letter
- Chairman’s Message
- Board of Directors
- Managing Directors’ Review of Operations
- Executive Team
- Patent / Trademark Status
- Directors' Report
- » Directors
- » Principle Activites
- » Review of Operations
- » Financial Performance
- » Changes in State of Affairs
- » Subsequent Events
- » Future Development
- » Dividends
- » Share Options
- » Indemnifaction of Officers and Auditors
- » Directors' Meeting
- » Directors' Shareholdings
- » Remuneration Report
- » Proceedings on behalf of the Company
- » Non-Audit Services
- » Auditor's Independence Declaration
- Corpoate Governance Report
- Auditor’s Independant Declaration
- Independent Audit report
- Directors’ Declaration
- Statement of Financial Performance
- Statement of Cash Flows
- Statement of Changes in Equity
- Notes to the Financial Statements
- Additional ASX Information
Future Development
